Nicholas Ck Valerie

7PUBLICATIONS
16CO-AUTHORS
Simulation, modelling, and programming of mechatronics systemsCheminformatics and quantitative structure-activity relationshipsMolecular targetsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 05, 2026
A modular lentiviral system for multiplexed gene perturbation and functional analysis suggests interdependence of hormone receptors in breast cancer growth in vivo.

|Dec 06, 2024
Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM.

Nicholas C K Valerie, Kumar Sanjiv, Oliver Mortusewicz

|Nov 03, 2019
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.

Brent D G Page, Nicholas C K Valerie, Roni H G Wright

|Jan 19, 2018
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.

Brent D G Page, Nicholas C K Valerie, Roni H G Wright

|May 17, 2017
Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors.

Sabin Llona-Minguez, Andreas Höglund, Artin Ghassemian

|Jan 10, 2017
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.

Nikolas Herold, Sean G Rudd, Linda Ljungblad

Pageof 2

Frequent Collaborators

4 joint publications

Sabin Llona-Minguez

2 joint publications

Sean G Rudd

2 joint publications

Mikael Altun

1 joint publications

Nikolas Herold